1.Effects of ischemic postconditioning on nitric oxide and nitric oxide synthase in diabetic rat brain tissues
Yingyun LU ; Guangjun ZHAO ; Yanna YANG ; Ying LIU ; Cuilan WANG
Journal of Chinese Physician 2014;(6):731-733,738
Objective To investigate effects of ischemic postconditioning on the nitric oxide ( NO) and nitric oxide synthase ( NOS) in diabetic rat brain tissues .Methods Thirty Wistar rats were diabetic models induced by intraperitoneal injuction of stepto-zotocin (STZ), and randomly divided into three groups: Control group (normal, diabetic), cerebral ischemia group, and ischemic postconditioning ( I-POST) group.The rats of cerebral ischemia group and ischemic postconditioning group were made model of cere -bral ischemia by ligation carotid artery .Hematoxylin-eosin ( HE) was used to observe their pathological changes in control and diabetic groups.Enzyme-linked immunosorbent assay ( ELISA) method was used to detect the expression and changes of NO and NOS in the sera in each group .Western Blot method was used to investigate the expression and changes of NOS in the retinal tissues in each group .Results For I-POST group , brain tissue defects were decreased , neuronal cells were increased , serum inducible NOS ( iNOS) content was significantly lower than endothelial NOS (eNOS) and neuronal NOS (nNOS) ( P <0.05), brain tissue iNOS expression was significantly weaker than ischemia group ( P <0.05 ) and was not different from normal group ( P >0.05 ) .Conclusions Is-chemic postconditioning can protect the brain tissue of diabetic rats by inhibiting NOS activity especially iNOS .
2.Effect of blood circulation punching apparatus on vital signs and thrombus of lower extremity veins in patients with cerebrovascular disease and hypertension
Yanna FAN ; Ranyun ZHOU ; Xin LU ; Min ZHANG ; Dan YU ; Yan ZHAO
Modern Clinical Nursing 2017;16(1):9-12
Objective To explore the effect of blood circulation punching apparatus on important vital signs and thrombus of lower extremity veins in stable blood pressure and normal cardiopulmonary function patients with cerebrovascular disease and hypertension and to evaluate safety and effectiveness of the apparatus for these patients.Methods We treated 30 patients with cerebrovascular disease and hypertension by blood circulation punching apparatus for 3 days,2 times per day,30 minutes per time.We monitored vital signs of these patients 15 minutes pre-,intra-and post-treatment.The thrombus of lower extremity veins and adverse reactions were observed during the treatment.Results We compared systolic pressure,diastolic pressure,pulse and breathe of patients 15 minutes pre-,intra-and post-treatment respectively.We didn't find any significant differences between these parameters.No patient had thrombus of lower extremity veins and adverse reactions in the hospital.Conclusion The blood circulation punching apparatus is suitable for cerebrovascular and hypertension patients with stable blood pressure and normal cardiopulmonary function and can prevent thrombus of lower extremity veins effectively.
3.Prognostic value by combination of angiographic and clinical characteristics in stenting patients with unprotected left main coronary artery lesion
Huiming YE ; Jianjun PENG ; Lihui REN ; Yanna LU ; Hao JIANG ; Ping WANG ; Guiyu XU ; Fu GUAN ; Shuixiang YANG
Chinese Journal of Geriatrics 2012;31(6):454-457
Objective To compare the predicting values for Prognosis among Global Risk Classification (GRS),Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) score,the European System for Cardiac Operative Risk Evaluation (EuroSCORE) in patients who received stenting because of unprotected left main coronary artery (ULMCA) lesion.Methods Totally 105 successive elderly patients with ULMCA lesion who received stenting were divided into 2 groups:with and without main adverse cardiac events (MACE).The clinical and angiographic characteristics were analyzed and then compared among GRC,SYNTAX score and EuroSCORE.Results As compared with none MACE group,MACE group had higher EuroSCORE score (2.0±2.3 vs.6.5±2.9,t=8.18,P=0.002),and more trivessel disease and left main bifurcation lesion (x2 =8.96,6.96,P =0.011,P =0.008).High risk GRC showed more MACE than medium or low risk GRC [55.9% (19/34) vs.20.5%(9/44),7.4% (2/27),x2 =19.77,P=0.001].AUC(95%CI )of GRC,SYNTAX score and EuroSCORE were [0.821 (0.730-0.912),0.586(0.462-0.709) and 0.631 (0506-0.757)],respectively.Compared with SYNTAX score and EuroSCORE,GRC was superior in the MACE predicting value (Z=3.29,2.63,P<0.01 or P<0.05).
4.The clinico-pathologic characteristics of the very elderly Chinese patients with kidney disease
Xiyan LIAO ; Yanna DOU ; Shan LU ; Genyang CHENG ; Jing XIAO ; Zhanzheng ZHAO ; Dong LIU
Chinese Journal of Geriatrics 2018;37(2):183-187
Objective To evaluate the clinico-pathologic presentations and prognosis in the very elderly patients undergoing renal biopsy.Methods The patients who underwent renal biopsy in Nephrology Center of the First Affiliated Hospital of Zhengzhou University were screened from May 2012 to March 2016.All patients were divided into observation group (aged ≥80 years) and control group (aged 65-70 years).The clinico-pathological classifications and prognosis were compared between the two groups.Results Primary glomerulopathy was the most frequent pathologic diagnosis in observation and control groups[20(60.6%) and 64(64.0%),respectively,P=0.726].Among primary glomerulopathy,membranous nephropathy was the most frequent histopathological type[10(50.0%) and 40 (62.5%)] in observation and control groups,respectively,(P =0.320).Among secondary glomerulopathy,the number of patients in observation group were 10 cases (30.3%) and were 13 cases (13.0%) in control group (t=5.194,P<0.05),with no significant differences between the two groups in amyloid degeneration,ANCA-associated vasculitis,HBV-associated Glomerulonephritis,and nephritis of Schonlein-Henoch purpura.In the very elderly patients with nephrotic syndrome,glomerular minimal change was the most common histological type [7 (30.4%)],followed by membranous nephropathy[6 (26.1%)].Furthermore,there were no side effects of perinephric hematoma,gross hematuria,arteriovenous fistula or other complications.Conclusions The pathological types distribution of patients aged ≥ 80 versus 65-70 years is different.And the renal biopsy is relatively safe and has an important role for the very elderly patients.
5.Phenotypic and Molecular Characteristics of Children with Progressive Familial Intrahepatic Cholestasis in South China
Wen ZHANG ; Ruizhu LIN ; Zhikun LU ; Huiying SHENG ; Yi XU ; Xiuzhen LI ; Jing CHENG ; Yanna CAI ; Xiaojian MAO ; Li LIU
Pediatric Gastroenterology, Hepatology & Nutrition 2020;23(6):558-566
Purpose:
Progressive familial intrahepatic cholestasis (PFIC) is a rare genetic autosomal recessive disease caused by mutations in ATP8B1, ABCB11 or ABCB4. Mutational analysis of these genes is a reliable approach to identify the disorder.
Methods:
We collected and analyzed relevant data related to clinical diagnosis, biological investigation, and molecular determination in nine children carrying these gene mutations, who were from unrelated families in South China.
Results:
Of the nine patients (five males, four females) with PFIC, one case of PFIC1, four cases of PFIC2, and four cases of PFIC3 were diagnosed. Except in patient no. 8, jaundice and severe pruritus were the major clinical signs in all forms. γ-glutamyl transpeptidase was low in patients with PFIC1/PFIC2, and remained mildly elevated in patients with PFIC3. We identified 15 different mutations, including nine novel mutations (p.R470HfsX8, p.Q794X and p.I1170T of ABCB11 gene mutations, p.G319R, p.A1047P, p.G1074R, p.T830NfsX11, p.A1047PfsX8 and p.N1048TfsX of ABCB4 gene mutations) and six known mutations (p.G446R and p.F529del of ATP8B1 gene mutations, p.A588V, p.G1004D and p.R1057X of ABCB11 gene mutations, p.P479L of ABCB4 gene mutations). The results showed that compared with other regions, these three types of PFIC genes had different mutational spectrum in China.
Conclusion
The study expands the genotypic spectrum of PFIC. We identified nine novel mutations of PFIC and our findings could help in the diagnosis and treatment of this disease.
6.Construction of standardized training program for post-entry nursing postgraduates
Yanan LI ; Mengke MA ; Yanna CAI ; Fenghua LU ; Wenying WANG ; Qiaozhi SUN ; Xiaoping LOU
Chinese Journal of Practical Nursing 2022;38(34):2641-2653
Objective:To construct a standardized training program for full-time nursing postgraduate students, and to provide a basis for the training the high-quality nursing talents in hospitals.Methods:Through literature review and demi structured interview, preliminarily develop the training program was established from January to March 2021. Through two rounds of expert consultations of 16 experts, the standardized training program for nursing postgraduates was formulated.Results:The recovery rate of the two rounds were both 16/16. The expert authority coefficients of the two rounds of consultation were 0.819, respectively. The Kendall′s coordination coefficients of the two rounds of consultation were 0.329 and 0.334, respectively, and the difference was statistically significant ( P< 0.01). Finally, a standardized training program for entry-level nursing postgraduates was formed, which included five parts: training objects and quality requirements, training methods, training objectives, training contents and evaluation, with a total of 225 items. Conclusions:The standardized training program for nursing postgraduates formed is reliable, scientific and practical, which provides guidance and reference for the training and use of highly educated clinical nursing talents in hospitals.
8.Amelioration of Cognitive Dysfunction in Diabetic Rats by Jianpi Qinghua Prescription
Qiuyue GUO ; Yanna GENG ; Xu HAN ; Jing TIAN ; Jie LI ; Qingguang CHEN ; Hao LU
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(8):195-202
ObjectiveTo explore the amelioration of cognitive dysfunction in diabetes mellitus (DM) by Jianpi Qinghua prescription (JPQH) based on type 2 diabetes (T2DM) model rats. MethodFifty healthy male Wistar rats of SPF grade were randomly divided into control group (n=10) and experimental group (n=40). The rats in the control group were fed conventionally, while those in the experimental group were fed on a high-sugar, high-fat diet for six weeks and administered with streptozotocin (STZ) for the induction of the DM model. The model rats were randomly divided into model group, sitagliptin group (1.2 g·L-1), pioglitazone group (0.8 g·L-1), and JPQH group (1.3 g·mL-1), with 10 rats in each group. After six weeks of drug intervention, the changes in body weight, blood glucose, and other related indexes of each group were recorded. Enzyme-linked immunosorbent assay (ELISA) was performed to detect the levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) in the peripheral blood and brain. The Morris water maze test was used to evaluate the cognitive function in rats. Hematoxylin-eosin (HE) staining was used to observe the pathological morphology of the hippocampal CA region. The amyloid β-protein 40 (Aβ40) level was detected by immunohistochemistry. The protein expression of t-tau and p-tau in hippocampal neurons of rats was detected by Western blot. ResultCompared with blank group, the body weight of model group was significantly decreased (P<0.05), blood glucose level was significantly increased (P<0.01), inflammatory cytokines TNF-α and IL-1β were increased (P<0.05), learning and spatial ability were significantly decreased (P<0.01), the arrangement of hippocampal cells was loose and disordered, and the intercellular space was significantly increased. The number of cells decreased significantly, and the expression of Aβ40 increased significantly. and increased t-tau and p-tau protein content in the hippocampus (P<0.01). Compared with model group, the JPQH group showed reduced blood glucose (P<0.01), decreased TNF-α and IL-1β levels in the peripheral blood and cerebrospinal fluid (P<0.05), a downward trend of IL-6 without a statistical difference, improved learning and spatial memory ability (P<0.01), densely arranged cells in the hippocampal CA1 area, increased cell number, reduced Aβ40 expression, and decreased p-tau protein expression (P<0.05). ConclusionJPQH can prevent cognitive dysfunction in DM by reducing inflammatory factor levels, decreasing neurotoxicity caused by Aβ40 deposition, and inhibiting hyperphosphorylation of tau protein in DM rats.
9.Clinical features of pyruvate dehydrogenase complex deficiency and gene testing in one case.
Moling WU ; Li LIU ; Yanna CAI ; Huiying SHENG ; Jing CHENG ; Xiuzhen LI ; Xi YIN ; Zhikun LU ; Ruizhu LIN ; Zhizi ZHOU ; Liping FAN ; Hongsheng LIU
Chinese Journal of Pediatrics 2014;52(11):863-866
OBJECTIVETo analyze the clinical characteristics and genetype of one children who had been diagnosed with pyruvate dehydrogenase complex deficiency.
METHODComprehensive analyses of this case were performed, including clinical symptoms, signs, biochemical examinations and therapeutic effects. The eleven exons and splicing areas of PDHA1 were amplified with genomic DNA from whole blood. And variations were investigated by sequencing the PCR product. The patient was diagnosed with pyruvate dehydrogenase complex deficiency by sequence analysis of PDHA1 gene.
RESULTThe patient was a 2 years and 4 monthes old boy. He presented with muscle hypotonia and weakness for one year, and experienced recurrent episodes of unstable head control, unable to sit by himself or stand without support, with persistently hyperlactacidemia. Metabolic testing revealed blood lactate 5.37 mmol/L, pyruvate 0.44 mmol/L, and lactate/pyruvate ratio was 12.23. MRI of the brain showed hyperintense signals on the T2 and T2 Flair weighted images in the basal ganglia bilaterally. Sequence analysis of PDHA1 gene showed a G>A point mutation at nucleotide 778, resulting in a substitution of glutarnine for arginine at position 263 (R263Q). And the diagnosis of pyruvate dehydrogenase complex deficiency was identified. By giving the therapy with ketogenic diet, vitamin B(1), coenzyme Q(10) and L-carnitine , the boy was in a stable condition.
CONCLUSIONThe severity and the clinical phenotypes of pyruvate dehydrogenase complex deficiency varied. Sequence analysis of PDHA1 gene revealed a 788G>A (R263Q) mutation. Patients who presented with unexplained muscle hypotonia, weakness and hyperlactacidemia could be diveded by gene analysis. And appropriate treatment can improve the quality of life.
Brain ; Carnitine ; Child, Preschool ; Exons ; genetics ; Humans ; Magnetic Resonance Imaging ; Male ; Mutation ; Phenotype ; Pyruvate Dehydrogenase (Lipoamide) ; genetics ; Pyruvate Dehydrogenase Complex Deficiency Disease ; diagnosis ; genetics ; Pyruvic Acid
10.Tat-functionalized Ag-FeO nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery.
Ergang LIU ; Meng ZHANG ; Hui CUI ; Junbo GONG ; Yongzhuo HUANG ; Jianxin WANG ; Yanna CUI ; Weibing DONG ; Lu SUN ; Huining HE ; Victor C YANG
Acta Pharmaceutica Sinica B 2018;8(6):956-968
In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide (Tat), producing Tat-modified Ag-FeO nanocomposites (Tat-FeAgNPs). To load drugs, an -SH containing linker, 3-mercaptopropanohydrazide, was designed and synthesized. It enabled the silver carriers to load and release doxorubicin (Dox) in a pH-sensitive pattern. The delivery efficiency of this system was assessed using MCF-7 cells, and using null BalB/c mice bearing MCF-7 xenograft tumors. Our results demonstrated that both Tat and externally applied magnetic field could promote cellular uptake and consequently the cytotoxicity of doxorubicin-loaded nanoparticles, with the IC of Tat-FeAgNP-Dox to be 0.63 µmol/L. The delivery efficiency of Tat-FeAgNP carrying Cy5 to the mouse tumor was analyzed using the optical imaging tests, in which Tat-FeAgNP-Cy5 yielded the most efficient accumulation in the tumor (6.7±2.4% ID of Tat-FeAgNPs). Anti-tumor assessment also demonstrated that Tat-FeAgNP-Dox displayed the most significant tumor-inhibiting effects and reduced the specific growth rate of tumor by 29.6% ( = 0.009), which could be attributed to its superior performance in tumor drug delivery in comparison with the control nanovehicles.